Screener
InMed Pharmaceuticals INM Q4 2024 earnings
Reported February 12, 2025 · Before market open
Revenue$772.5M
EPS-$3.64
Next report
Sep 23, 2026 (In 4 days)Revenue estimate$2.1B
EPS estimate-$94.44
Versus estimates
Revenue
Diluted EPS
FAQ
- When did InMed Pharmaceuticals report Q4 2024 earnings?
- InMed Pharmaceuticals (INM) reported Q4 2024 earnings on February 12, 2025 before market open.
- What were InMed Pharmaceuticals's Q4 2024 revenue and EPS?
- InMed Pharmaceuticals reported revenue of $772.5M and eps of $-3.64 for Q4 2024.
- Where can I find InMed Pharmaceuticals's Q4 2024 SEC filings?
- You can read the 8-K earnings release (0001213900-25-013204) and the 10-Q periodic report (0001213900-25-013063) directly on SEC EDGAR. The filing index links above go to sec.gov.
